AstraZeneca COVID-19 Vaccine Trial Data Questioned By Safety Board-NPR

A safety board overseeing AstraZeneca's COVID-19 vaccine trial is raising concerns about the company's data. In an unusual post-midnight statement, the National Institute of Allergy and Infectious Diseases said the Data and Safety Monitoring Board, which monitors the trial, is concerned that "outdated information" may have been included in the trial results. NPR, 03/23/2021

•   Print
•   Email
•   Share
•   Tweet